Prevalence of Sarcopenia in Patients With COVID-19: A Systematic Review and Meta-Analysis.

ABSTRACT:

Background

It has been speculated that patients with sarcopenia are aggravated by the current novel coronavirus disease 2019 (COVID-19) epidemic. However, there is substantial uncertainty regarding the prevalence of sarcopenia in patients with COVID-19.

Objectives

The purpose of the study was to systematically evaluate the prevalence of sarcopenia in patients with COVID-19, including stratification by gender, study location, study population, study design, and diagnostic criteria.

Design

This is the systematic literature review and meta-analysis.

Methods

An electronic search was performed in MEDLINE/PubMed, Embase, Cochrane Library, and Web of Science and Scopus to identify observational studies reporting a prevalence estimate for sarcopenia in patients with CO

SUBMITTER: Xu Y 

PROVIDER: S-EPMC9289534 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature